(HEXAHYDRO-7-METHYL-4-(PHENYLMETHYL)-1H-1,4-DIAZEPIN-1-YL)(5-METHYL-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE
UNII HQ2X25D3A3
Substance Identification & Data
This profile provides standardized clinical and technical data for (hexahydro-7-methyl-4-(phenylmethyl)-1h-1,4-diazepin-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HQ2X25D3A3.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2705397-83-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H27N5O DRWURUAZLCYLTK-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (hexahydro-7-methyl-4-(phenylmethyl)-1h-1,4-diazepin-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.